Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.63)
# 2,072
Out of 4,893 analysts
209
Total ratings
25.94%
Success rate
0.68%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.36 | +561.76% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.67 | +1,099.58% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.15 | +208.94% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.45 | +63.27% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.16 | -7.41% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.53 | +1,398.13% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.27 | +481.04% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.07 | +914.49% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.51 | +497.61% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $1.23 | +4,471.43% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.35 | +640.74% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.50 | +300.00% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $28.50 | +5.26% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.09 | +167.98% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.65 | +53,746.15% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.46 | +363.10% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.00 | +503.02% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.63 | +6,034.97% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.04 | +1,630.77% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.29 | +773.36% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $8.00 | +196,775.00% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $12.35 | +3,948.58% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $17.55 | +1,267.52% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.93 | +8,502.15% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.80 | +12,400.00% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.77 | +138,464.13% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.38 | +407.25% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.46 | +1,119.51% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.33 | +1,616.74% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.82 | +371.20% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.45 | +104.08% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $6.11 | +23,467.92% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $36.57 | -34.37% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $2.03 | +168,372.91% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $2.15 | +883,620.93% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.36
Upside: +561.76%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.67
Upside: +1,099.58%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.15
Upside: +208.94%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.45
Upside: +63.27%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.16
Upside: -7.41%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.53
Upside: +1,398.13%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.27
Upside: +481.04%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.07
Upside: +914.49%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.51
Upside: +497.61%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $1.23
Upside: +4,471.43%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.50
Upside: +300.00%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $28.50
Upside: +5.26%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.09
Upside: +167.98%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.65
Upside: +53,746.15%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.46
Upside: +363.10%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.00
Upside: +503.02%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.63
Upside: +6,034.97%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.04
Upside: +1,630.77%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.29
Upside: +773.36%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $8.00
Upside: +196,775.00%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $12.35
Upside: +3,948.58%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $17.55
Upside: +1,267.52%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.93
Upside: +8,502.15%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.80
Upside: +12,400.00%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.77
Upside: +138,464.13%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.38
Upside: +407.25%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.46
Upside: +1,119.51%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.33
Upside: +1,616.74%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $3.82
Upside: +371.20%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.45
Upside: +104.08%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $6.11
Upside: +23,467.92%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $36.57
Upside: -34.37%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $2.03
Upside: +168,372.91%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $2.15
Upside: +883,620.93%